Latest filing published 28 Mar 2017 for Fresh Tracks Therapeutics, Inc., €8,491.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Anthony Alan Ramos: trading record in brief
Anthony Alan Ramos discloses dealings in Fresh Tracks Therapeutics, Inc. to SEC (Form 4). Over a trading history stretching from 19 April 2013 to 27 March 2017, the count stands at 29 filings.
Market trades split into 2 purchases (€73k) and 12 sales (€31k). Purchases outweigh sales by €42k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 15 share grants. In 2017 alone, the filings show no purchases and 1 sale.
Most recently, on 28 March 2017, the filings show an open-market sale worth €8,491 in Fresh Tracks Therapeutics, Inc. The clock since the last published purchase (14 January 2014) now reads 4,682 days. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Anthony Alan Ramos
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,250 shares@ US$2.1778.7% of flowCommon Stock $.01 par valueSEC:0001209191-17-023156:0
- 7,500 shares@ US$0.330320.7% of flowCommon Stock $.01 par valueSEC:0001209191-16-100841:0
- 193 shares@ US$0.351100.0% of flowCommon Stock $.01 par valueSEC:0001209191-16-093574:0
- 193 shares@ US$0.39Common Stock $.01 par valueSEC:0001209191-15-076862:0
- 194 shares@ US$0.62Common Stock $.01 par valueSEC:0001209191-15-062475:0
- 193 shares@ US$1.01Common Stock $.01 par valueSEC:0001209191-15-036312:0
- 428 shares@ US$1.09Common Stock $.01 par valueSEC:0001209191-15-005875:0
- 60,000 shares@ US$0.01Common Stock $.01 par valueSEC:0001209191-15-005634:0
- 428 shares@ US$1.18Common Stock $.01 par valueSEC:0001209191-14-064262:0
- 12,500 shares@ US$1.25Common Stock $.01 par valueSEC:0001181431-14-030243:0
- 428 shares@ US$1.29Common Stock $.01 par valueSEC:0001181431-14-027100:0
- 428 shares@ US$1.22Common Stock $.01 par valueSEC:0001181431-14-016616:0
- 82 shares@ US$1.59Common Stock $.01 par valueSEC:0001181431-14-003981:0
- 209 shares@ US$1.49Common Stock $.01 par valueSEC:0001181431-14-003981:1
- 164 shares@ US$1.66Common StockSEC:0001209191-14-004417:0
- 164 shares@ US$1.66Common StockSEC:0001209191-14-004417:1
- 70,000 shares@ US$0.01Common Stock $.01 par valueSEC:0001181431-14-002567:0
- 70,000 shares@ US$1.42Common Stock $.01 par valueSEC:0001181431-14-002329:0Canonical exit: 10 Apr 2014 (T+90)
- 7,918 shares@ US$1.11Common Stock $.01 par valueSEC:0001181431-13-059000:0
- 82 shares@ US$1.49Common Stock $.01 par valueSEC:0001181431-13-055045:0
- 163 shares@ US$1.34Common Stock $.01 par valueSEC:0001181431-13-054651:0
- 163 shares@ US$1.36Common Stock $.01 par valueSEC:0001181431-13-054651:1
- 25,000 shares@ US$0.01Common Stock $.01 par valueSEC:0001181431-13-046540:0Canonical exit: 24 Nov 2013 (T+90)
- 83 shares@ US$3.35Common Stock $.01 par valueSEC:0001181431-13-041218:0
- 164 shares@ US$3.62Common Stock $.01 par valueSEC:0001181431-13-040968:0
25 of 29 declarations
